LB-100 Clinical Trials
3 recruitingDrug
Phase 13Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
Ovarian Clear Cell Carcinoma
M.D. Anderson Cancer Center21 enrolled1 locationNCT06065462
Recruiting
Phase 1
LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
Metastatic Microsatellite-stable Colorectal Cancer
The Netherlands Cancer Institute37 enrolled1 locationNCT06012734
Recruiting
Phase 1Phase 2
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes
Lixte Biotechnology Holdings, Inc.47 enrolled1 locationNCT03886662